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Summary
Introduction: High-resolution computed tomography (HRCT) is a widespread medical
imaging method for the study of thoracic diseases. In asthma  it is very useful particularly
when it is difficult to achieve an effective control of disease, and in severe deterioration.
Aim: It was intended to evaluate the imaging changes by HRCT in asthmatic patients
and to assess the expression according to the symptoms and duration of disease. Material
and methods: Thirty three patients from the Outpatient Department, with asthma clas-
sified in the different clinical severity stages according to GINA, were randomly includ-
ed. They were submitted to HRCT (Somaton Plus-4, Siemens®). The lesions were clas-
sified in reversible (mucoid impaction, acinar pattern centrilobular nodules and lobar
collapse) and irreversible (bronchiectasis, bronchial wall-thickening, sequellar line shad-
ows and emphysema). Results: The 33 asthmatic patients (20 female) had an average
age of 44.76±16.98 years and a mean disease evolution time of 23.39±14.83 years. 30%
had mild persistent asthma, 43% moderate persistent asthma and 27% severe persistent
asthma. All the patients were under inhaled corticotherapy. Only 6 patients had normal
HRCT: 4 with mild persistent asthma (4 to 25 years of duration of disease) and 2 with
moderate persistent (10 to 48 years of duration of disease). 81.81% of the patients had
changes in HRCT, being the irreversible lesions the most frequent. The most important
irreversible lesions were observed in severe asthma patients with longer duration of dis-
ease. All the patients with reversible lesions had also irreversible changes. Most of the
bronchiectasis were centrally located and were found in severe asthma patients. Irre-
versible changes were identified in 3 patients with mild asthma and a maximum of 6
years of duration of disease. Discussion: HRCT findings were related with asthma
severity and long lasting disease but there are some asthmatics that also present early ab-
normalities, even in milder forms. All the groups of asthmatic patients presented all types
of imaging changes, including the irreversible ones. In asthma these changes can be the
result of individual patterns of response to frequent exacerbations, leading to a persistent
chronic inflammatory process that will determine airway remodelling, even in early
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Introduction
Bronchial asthma is characterised by reversible airflow
obstruction and bronchial hyperresponsiveness (1, 2). It is
a chronic inflammatory disease, where most patients can
achieve complete reversibility with bronchodilators and/or
anti-inflammatory medications (2, 3). However, in many
asthmatics this inflammatory condition can be followed
by healing that may result in an altered structure, due to
the remodelling of the airways (3, 4). Structural changes
can occur in central and peripheral small airways and are
thought to result in an irreversible component of the air-
way obstruction seen in asthma and perhaps also in the
development of airway hyperresponsiveness (1, 2, 5). Pa-
tients with an irreversible airflow obstruction can experi-
ence considerable morbidity and account for a high per-
centage of the health costs related to asthma (6).
The detection and quantification of airway remodelling
have been based on histological examination (7). Howev-
er, the development of high resolution computed tomog-
raphy (HRCT) has provided a potential non-invasive
technique for its measurement in vivo, even though the
information that can be obtained from HRCT is essen-
tially less detailed than that obtained on histological ex-
amination (6, 7).
With conventional chest radiography one can only evi-
dence a limited number of abnormalities in asthmatic pa-
tients (8.
The dimensions of the central airway in patients with
asthma can be assessed quantitatively by computed to-
mography (CT), but these measures are considered indi-
rect measures of airway remodeling and analysis of the
wall area or luminal area of small airways are beyond the
spatial resolution of conventional CT9,10. Measures de-
rived from full-expiratory scans by HRCT can indicate
the presence of air trapping in asthma (2, 9, 11) and hy-
perlucency should identify hyperinflation (12). Subse-
quently, HRCT has been tried as an alternative procedure
and some authors describe its potentiality in evaluating
the airways in patients with asthma (2, 13). The HRCT
scans of asthmatics patients have shown both decreased
and increased bronchial lumen area, excessive airway nar-
rowing in response to a variety of stimuli and airway wall
thickening, in addition to mosaic perfusion and gas trap-
ping on expiration (7).
The aim of this study was to evaluate the imaging
changes by HRCT in asthmatic patients and to assess
their relationship with the clinic and the duration of dis-
ease.
Methods
Subjects: The patients were selected from our outpatient
department. During 33 consecutive weeks we selected the
first adult asthmatic patient that had a scheduled appoint-
ment each Monday. All the patients were non-smokers,
with previous clinical and functional diagnosis of asthma,
according to the GINA criteria (14). They should be un-
der appropriate optimized therapy, according to clinical
severity. Demographic and clinical data such as age, dura-
tion of disease, medication used and severity of disease
were taken into account. Allergic sensitizatisation was de-
fined by positive skin-prick tests to common aeroallergens
(Leti, Spain) and/or serum specific IgE levels higher than
0.35 kU/L for at least one allergen.
Only the patients without respiratory infections or exac-
erbations of asthma in the last month were selected for
this study. Written informed consent was obtained from
all the subjects.
HRCT image acquisition: CT scans were performed using
a single detector device (Somaton Plus 4; Siemens, Erlan-
gen, Germany). Two sets of 15 to 20 images (according to
the size of the patient’s thorax) were acquired at full in-
spiration. The scans were performed on the whole lung
using a sequential mode (1 mm section thickness at 20
mm increment intervals), in order to get images from the
apices to the diaphragm. CT scans were performed using
the following parameters: 120 kV, 200 mAs, pitch 1,0 and
0.5 to 1 second rotation time.
The images were reconstructed using a high spatial reso-
lution algorithm and visualized with a window setting of
1500 Hounsfield units (HU) width and -700 HU level.
The scans were sequentially interpreted by two radiolo-
gists that did not have any previous knowledge about the
chest X-ray and the clinical severity of the disease. Both
internal and external diameters of the apical bronchus of
the right upper lobe were measured in order to evaluate
the agreement between the 2 observers. Consensus read-
ing was regarded as the average of the two observer’s
measurements.
The following lesions were taken into consideration for
the proposal of analysis: reversible and irreversible, and
classified from mild to severe (+ to +++). Several HRCT
scan abnormalities were annotated: reversible lesions as
mucoid impaction, acinar pattern and lobar collapse, and
irreversible forms of damage as bronchiectasis, bronchial
wall thickening, sequellar line shadows and emphysema (4).
All the data was collected and analyzed, in order to iden-
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tify possible relationships between the changes in HRCT
and clinical characteristics of the patients.
Statistical analysis: Statistical analysis was performed with
SPSS 15.0 (2006 SPSS Inc, Chicago, Ill, USA). Distribu-
tion of frequencies was obtained for the different groups
of patients. Additionally, average and standard deviation
were calculated for quantitative variables. Association be-
tween allergic sensitization and abnormal HRCT scans
was evaluated by chi-square tests (Pearson or Fisher’s ex-
act test). Differences between patients with more than
one irreversible lesion and those with only one as well as
patients with more than one reversible lesion and those
with only one were analysed by Mann-Whitney U test.
Significance was considered for a p value less than 0.05.
Results
Thirty-three patients were included, 20 female and 13
male. The mean age of the sample was 44.76±16.98 years
old and the mean duration of disease was 23.39±14.83
years old. According to the clinical classification 30% of
the sample had mild persistent, 43% moderate persistent
and 27% severe persistent (Table 1). Allergic sensitization
was present in 24:33 patients (house dust mites=16; grass
pollen=7; mites and grass pollen=2).
All the subjects were under optimized therapy, according
to clinical and functional severity, namely inhaled corti-
costeroids. No patient was under immunotherapy or were
previously submitted to this treatment. No one had sys-
temic corticosteroids therapy in the last 6 months either.
Table 2 shows the clinical and radiological characteriza-
tion of the patients. A full concordance of imaging results
interpretation was obtained from the two imagiologists.
Only 6 out of 33 patients had HRCT without changes
(Table 1). These patients had a mean age of 35.83±17.99
years and 16.50±17.22 years of duration of disease. From
these patients, 4 had mild persistent (duration of disease
10.25±9.88 years; 4 to 25 years) and 2 moderate persistent
asthma (duration of disease 29.00±26.87 years; 10 and 48
years). The other 29 patients (81.81%) showed abnormal-
ities, as outlined in Tables 1 and 2; the mean age of these
patients was 46.74±16.44 years, with a duration of disease
of 24.93±14.15 years. Despite a higher frequency of ab-
normal HRCT scans in atopic patients compared to non
atopic (20 versus 7 patients), these differences had no sta-
tistical significance (p=0.533).
The most common irreversible lesion was bronchial wall
thickening (69.7%), followed by bronchiectasis (45.5%),
sequellar line shadows (30.3%) and emphysema (24.2%)
(Figures 1 and 2).
Bronchial wall thickening was found in 88.9% of the pa-
tients with severe persistent, in 78.6% with moderate per-
sistent and in 40% of the mild persistent asthma patients.
In the majority of patients, the bronchiectasis were cen-
trally located (86.7%). These patients had mostly severe
forms of ashtma. Nonetheless, 2 patients with mild per-
sistent asthma had also bronchiectasis. These lesions were
present in 77.7% of the patients with severe persistent,
42.9% of the moderate persistent patients and in 20% of
those with mild persistent asthma.
Ten patients had sequellar line shadows shown by HRCT.
This lesion was found in 66.7% of patients with severe
Thoracic high resolution computed tomography (HRCT) in asthma
Table 1 - Summary of the radiological lesions, according to the asthma severity classification.
Mild persistent Moderate persistent Severe persistent Total
Total of patients 10 14 9 33
Irreversible lesions Bronchial wall thickening 4 11 8 23
Bronchiectasis 2 6 7 15
Sequellar line shadows 0 4 6 10
Emphysema 0 4 4 8
Total of patients 26
Reversible lesions Acinar pattern 1 3 2 6
Lobar collapse 1 3 2 6
Mucoid impaction 0 1 0 1
Total of patients 7
Normal 4 2 0 6
 

































































































































































































































































































































































































































































































































































































































































































































































































































































































persistent and in 28.6% of the moderate persistent asthma
patients. None of the asthmatics with mild persistent
form showed this lesion.
Concerning emphysema, no mild persistent asthmatic
presented this lesion, however it was found in 28.6% of
the moderate persistent patients and in 44.4% of those
with severe persistent asthma.
The most important irreversible lesions were more com-
mon in patients with severe and long-lasting asthma.
Three patients with mild asthma and duration of disease
lesser than 6 months had irreversible lesions: 2 with bron-
chial wall thickening, one with central bronchiectasis and
another one with varicose bronchiectasis. The patients
with more than one irreversible lesion were older and had
a longer duration of disease, than those with only one:
53.31±14.12 versus 37.18±15.29 years (p=0.009) and
29.88±13.89 versus 17.73±11.61 years (p=0.064), respec-
tively. At least two irreversible lesions were more fre-
quently found in atopic patients than in non atopic (12
patients versus 4 patients), (p=0.081).
Reversible lesions were less common than the irreversible
ones. Moreover, all patients with reversible lesions had al-
so irreversible abnormalities. Patients with more than one
reversible lesion had a mean age of 40.75±17.11 years and
duration of disease of 22.75±14.29 years. Those with only
one reversible lesion had a mean age of 55.50±14.39
years, with a mean duration of disease of 27.00±15.17
years. These differences were not statistically significant.
Discussion
We studied non smoker asthmatic patients, in order to es-
tablish a relationship between the clinical severity, dura-
tion of disease and lesions detected by HRCT. The previ-
ous chest X-ray results obtained for all the patients did
not allowed to suspect the morphological abnormalities
showed by HRTC. The majority of the mild and moder-
ate asthmatic patients had normal images on chest X-ray,
and only the patients with severe forms or long lasting
asthma showed bronchial wall thickness features.
The prevalence of abnormal HRCT scans in our study
was higher, comparing to similar reports from other
groups; perhaps the degree of differentiation of our out-
patient clinic can explain this disparity. In a sample of 31
asthmatic adult patients with clinical and functional wors-
ening of disease submitted to chest radiographies and
thorax HRCT scans, Rimondi et al. found abnormal
HRCT scans in 61% of the patients (15). Vignola and co-
workers in a study of 30 asthmatic patients and 12 pa-
tients with chronic obstructive pulmonary disease de-
scribed 70% of abnormal HRCT scans among asthmatic
patients (16). Paganin and colleagues found 71.9% of ab-
normal HRCT scans, in a study with 57 asthmatic pa-
tients8. A study with 48 asthmatic patients, undertaken
by Lynch et al., described a higher abnormality rate than
our results, with 92% of the sample with abnormal
HRCT scans (17).
We found all types of imaging changes in all groups of
patients, including the irreversible ones, although the
Thoracic high resolution computed tomography (HRCT) in asthma
Figure 1 - HRCT scan image of a patient with varicose and cystic
bronchiectasis, sequellar line shadows and emphysema
Figure 2 - HRCT scan image of a patient with mucoid impaction
and bronchial wall-thickening
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most severe lesions were more frequently found in asth-
matic patients with the worst clinical impairment and
longer duration of disease. There are some previous stud-
ies that corroborate our findings. Awadh and co-workers
described that all groups of patients with near fatal attack
of asthma, even those with moderate and mild asthma
had greater airway wall thickening than the normal sub-
jects (13). In the same study they found a greater airway
wall thickening in the patients with the most severe
symptoms comparing with those with milder forms (13).
In a study comparing patients with near fatal, mild-to-se-
vere asthma, and healthy controls Lee YM et al did not
found significant differences in the bronchial wall thick-
ening between the different groups of patients (18).
We found a high frequency of irreversible lesions among
different groups of asthmatic patients even in those with
milder forms. All patients with abnormal HRCT scans
presented irreversible lesions. These severe injuries were
present in 81.81% of our sample, being the most frequent
bronchial wall thickening, followed by bronchiectasis, se-
quellar line shadows and emphysema.
Regardless of the majority of our patients being atopic,
the presence of HRCT scan abnormalities were not relat-
ed with allergic sensitization. Other groups found similar
results (9, 19).
Bronchial wall thickening is the result of airway remodel-
ling. It is considered an irreversible structural abnormality
in asthmatic patients (8, 18, 20), and can be responsible
for irreversible airflow obstruction and an increase in air-
way responsiveness (2). The airway wall thickness results
from mucosal infiltration with inflammatory cells, smooth
muscle hypertrophy, deposition of connective tissue, and
mucous gland hyperplasia (13). It has been demonstrated
that these structural changes can occur not only in the
central, but also in the peripheral small airways (2, 21).
Other studies have been suggesting an association be-
tween asthma severity and bronchial wall thickness (6,
13). Bronchial wall thickening was the most frequent irre-
versible lesion detected by HRCT in our study (69.7% of
the patients). This finding is corroborated by the results
of other studies, where this lesion was the most common,
but with different prevalence rates: 44% (Park et al.) (22)
and 92% (Lynch et al.) (17).
Bronchiectasis is recognized as an important cause of res-
piratory morbidity, particularly in developing countries
(23). We found bronchiectasis in 45.5% of our sample,
mainly centrally located and mostly in patients with se-
vere asthma. This percentage was lower than the data ob-
tained by other groups. Rimondi et al. reported this ab-
normality in 53.8% of the patients (15). In 1992, Paganin
and co-workers observed bronchiectasis, mostly cylindri-
cal, in 37 of 57 asthmatic patients (8). Another classic
study, undergone by the Lynch group, found a prevalence
of 77% of bronchiectasis among a group of 48 asthmatic
patients (17).
Another irreversible lesions found in our study were the
sequellar line shadows, present in 30.3% of our sample;
we did not found this lesions in patients with mild asth-
ma. Patients with this radiological pattern had a longer
duration of disease. Harmanci et al. correlated this radio-
logical pattern with the duration of asthma, in a group of
160 asthmatic patients (24).
The less frequent irreversible lesion was emphysema; nev-
ertheless it was observed in almost a quarter of the sam-
ple. This injury had been associated with severe asthma in
the past, but only recently its role in asthma was well es-
tablished; the use of HRCT scans, providing a high de-
gree of anatomical detail, was helpful in determining this
association (25).
In our sample, the irreversible lesions were dominant in
early-onset than in late-onset asthma. We also found this
type of severe abnormalities in younger patients and in
those with short duration of disease, suggesting an early
appearance of lesions.
In addition, patients with more than one lesion had a
longer duration of disease; however one patient from the
group of moderate persistent asthma and the longest dis-
ease evolution time had a normal HRCT scan.
We stress that some patients (ex. 7, 8 and 10) with mild
forms of asthma and with reduced duration of disease
have already irreversible lesions. Probably this could rep-
resent an expression of distinct phenotypes of asthma not
discriminated by a classical clinical classification.
Eight patients were studied 5 years later with another
HRCT scan (data not published). All of them were regu-
larly observed in the outpatient department. Two patients
changed their clinical severity pattern from moderate to
mild and from severe to moderate, respectively. We found
an increase of imaging abnormalities, with one patient
presenting cylindrical bronchiectasis, despite the excellent
clinical evolution and another one with a previous normal
CT scan, showing brochiectasis, in spite of the mainte-
nance of the same clinical severity.
The abnormalities described in our patients are probably
related to the remodelling process. The parenchymal and
airway changes that become irreversible throughout the
long course of the disease, as structural changes can occur
early during the course of disease (16, 26). In the past, Pa-
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ganin et al. demonstrated the reversibility of the remod-
elled airways, after antiasthmatic therapy, with mucoid
impaction, acinar patterns, and lobar collapse considered
reversible lesions; however, lesions as bronchial wall thick-
ness, bronchiectasis, and emphysema were described irre-
versible (8, 20). A more recent study illustrated bronchial
wall thickening as partially reversible, after intensive anti-
inflammatory therapy; however air trapping was not im-
proved18. It seems that bronchial wall thickening is re-
versible when submucosal inflammation or oedema pre-
dominates, and irreversible when the airways are remod-
elled extensively (18).
As outlined before, we believe that morphological abnor-
malities occur earlier at the beginning of the disease, proba-
bly delayed by anti-inflammatory therapy. Perhaps, there
are individual genetic factors, not yet clarified, that en-
hances or limits the remodelling and the severity of asthma.
It seems that the HRCT findings are related with asthma
severity and long lasting disease but there are some asth-
matics that also present early abnormalities, even in
milder forms. So this technique has a role in the manage-
ment of the asthmatic patients, namely for the early iden-
tification of bronchiectasis that need a convenient thera-
peutic approach.
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